DK229984D0 - 4-oxothiazolidin-2-yliden-acetamid-derivater - Google Patents

4-oxothiazolidin-2-yliden-acetamid-derivater

Info

Publication number
DK229984D0
DK229984D0 DK2299/84A DK229984A DK229984D0 DK 229984 D0 DK229984 D0 DK 229984D0 DK 2299/84 A DK2299/84 A DK 2299/84A DK 229984 A DK229984 A DK 229984A DK 229984 D0 DK229984 D0 DK 229984D0
Authority
DK
Denmark
Prior art keywords
ylidene
acetamide
derivatives
thiazolidin
oxo
Prior art date
Application number
DK2299/84A
Other languages
English (en)
Other versions
DK162048C (da
DK162048B (da
DK229984A (da
Inventor
Gerhard Satzinger
Manfred Herrmann
Edgar Fritschi
Johannes Hartenstein
Gerd Bartoszyk
Original Assignee
Goedecke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Goedecke Ag filed Critical Goedecke Ag
Publication of DK229984D0 publication Critical patent/DK229984D0/da
Publication of DK229984A publication Critical patent/DK229984A/da
Publication of DK162048B publication Critical patent/DK162048B/da
Application granted granted Critical
Publication of DK162048C publication Critical patent/DK162048C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Peptides Or Proteins (AREA)
DK229984A 1983-05-10 1984-05-09 4-oxothiazolidin-2-yliden-acetamidderivater, fremgangsmaade til deres fremstilling samt deres anvendelse DK162048C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3317000 1983-05-10
DE3317000A DE3317000C2 (de) 1983-05-10 1983-05-10 4-Oxo-thiazolidin-2-yliden-acetamid-derivate, Verfahren zu deren Herstellung und deren Verwendung bei der Bekämpfung von durch das Zentralnervensystem bedingten Konvulsionen

Publications (4)

Publication Number Publication Date
DK229984D0 true DK229984D0 (da) 1984-05-09
DK229984A DK229984A (da) 1984-11-11
DK162048B DK162048B (da) 1991-09-09
DK162048C DK162048C (da) 1992-02-10

Family

ID=6198604

Family Applications (1)

Application Number Title Priority Date Filing Date
DK229984A DK162048C (da) 1983-05-10 1984-05-09 4-oxothiazolidin-2-yliden-acetamidderivater, fremgangsmaade til deres fremstilling samt deres anvendelse

Country Status (19)

Country Link
US (1) US4563471A (da)
EP (1) EP0124911B1 (da)
JP (1) JPS59206372A (da)
AT (1) ATE65778T1 (da)
AU (1) AU565799B2 (da)
BG (2) BG41129A3 (da)
CA (1) CA1237436A (da)
CS (1) CS244814B2 (da)
DD (1) DD224319A5 (da)
DE (2) DE3317000C2 (da)
DK (1) DK162048C (da)
ES (2) ES532331A0 (da)
GR (1) GR82086B (da)
HU (1) HU190566B (da)
IE (1) IE57372B1 (da)
PL (2) PL142365B1 (da)
SU (2) SU1251803A3 (da)
YU (2) YU45183B (da)
ZA (1) ZA843489B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0269024A3 (en) * 1986-11-21 1990-05-09 Godecke Aktiengesellschaft Use of 3-methyl-4-oxothiazolidin-2-ylidene-acetamide derivatives in the treatment of aids
EP0494405B2 (en) * 1991-01-10 2000-04-19 Transcend Therapeutics, Inc. Use of L-2-oxo thiazolidine-4-carboxylate for the treatment of pulmonary diseases
US5747459A (en) * 1991-02-04 1998-05-05 Nestec, Ltd. Method for insuring adequate intracellular glutathione in tissue
US5430045A (en) * 1992-04-23 1995-07-04 Free Radical Sciences, Inc. Method of reducing or preventing bone marrow hypoplasia
US6133299A (en) * 1993-02-25 2000-10-17 Warner-Lambert Company Methods for treating neurodegenerative diseases and disorders using N-(2,6-disubstituted aromatic)-N'-pyridinyl ureas and other anticonvulsant compounds
US5447712A (en) * 1993-12-09 1995-09-05 Free Radical Sciences Method of reducing cyclophosphamide induced hemorrhagic cystitis
KR100329808B1 (ko) * 2000-01-14 2002-03-25 박호군 2-펜아실리덴-3,5-알킬치환된-1,3-티아졸리딘-4-온의 효율적 제조 방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1150985B (de) * 1961-03-06 1963-07-04 Warner Lambert Pharmaceutical Verfahren zur Herstellung von Thiazolidin-4-on-Derivaten
FR2726M (fr) * 1962-12-04 1964-08-17 Warner Lambert Pharmaceutical Amides de thiazolidinones substituées.
DE2423725C2 (de) * 1974-05-16 1982-12-30 Gödecke AG, 1000 Berlin 5-Phenyl-4-oxo-Delta 2,ALPHA-thiazolidinessigsäureester

Also Published As

Publication number Publication date
EP0124911A3 (en) 1987-02-04
BG41129A3 (en) 1987-04-15
ATE65778T1 (de) 1991-08-15
ES8502696A1 (es) 1985-01-16
HUT34174A (en) 1985-02-28
IE57372B1 (en) 1992-08-12
DK162048C (da) 1992-02-10
YU45183B (en) 1992-05-28
JPS59206372A (ja) 1984-11-22
YU63586A (en) 1986-10-31
AU2788984A (en) 1984-11-15
SU1272985A3 (ru) 1986-11-23
BG40143A3 (en) 1986-10-15
PL247581A1 (en) 1985-07-16
CA1237436A (en) 1988-05-31
DD224319A5 (de) 1985-07-03
DE3317000C2 (de) 1986-09-25
PL142398B1 (en) 1987-10-31
IE841150L (en) 1984-11-10
EP0124911A2 (de) 1984-11-14
DK162048B (da) 1991-09-09
GR82086B (da) 1984-12-13
PL252100A1 (en) 1985-11-05
CS244814B2 (en) 1986-08-14
PL142365B1 (en) 1987-10-31
ES532331A0 (es) 1985-01-16
ES532322A0 (es) 1985-01-01
ZA843489B (en) 1984-12-24
SU1251803A3 (ru) 1986-08-15
DE3317000A1 (de) 1984-11-15
YU79284A (da) 1986-10-31
EP0124911B1 (de) 1991-07-31
DK229984A (da) 1984-11-11
ES8502430A1 (es) 1985-01-01
AU565799B2 (en) 1987-10-01
HU190566B (en) 1986-09-29
DE3484859D1 (de) 1991-09-05
JPS6316386B2 (da) 1988-04-08
US4563471A (en) 1986-01-07

Similar Documents

Publication Publication Date Title
DE3366494D1 (de) New 6-substituted-s-triazolo(3,4-a)phthalazine derivatives
IT8347779A0 (it) Procedimento per il ricupero di ifn-b umano da microorganismi produttori trasformati
ATE10582T1 (de) Verfahren zur herstellung pharmazeutischer, darmloeslicher kapseln.
ATE38036T1 (de) Benzothiophenderivate als bronchodilatoren.
DE3884870D1 (de) Verfahren zur Herstellung von Vitamin-D-Derivaten.
DK229984A (da) 4-oxothiazolidin-2-yliden-acetamidderivater
ATE137237T1 (de) R-(-)-1-(5-hydroxyhexyl)-3-methyl-7- propylxanthin, verfahren zu dessen herstellung und diese verbindung enthaltende arzneimittel
ATE81499T1 (de) 2-acyloxypropylamin-derivate, verfahren zur herstellung und diese enthaltende arzneimittel.
HUT36783A (en) Process for preparing 1,7-diphenyl-3-methyl-aza-7-cyano-8-methyl-nonane
SE8404334D0 (sv) 16-fluoro-16,17-didehydro-prostanoids and process for their preparation
IS2902A7 (is) Aðferð til framleiðslu á 1,8-dihydroxy-10-acyl-9-anthrones, sérstaklega til meðferðar á psoriasis
IT1163567B (it) Apparecchio di diluizione, specialmente per la fabbricazione di medicinali omeopatici
DE68915750D1 (de) Kathecholverbindungen, verfahren zur herstellung und arzneimittelzubereitung, die diese enthält.
NO884635L (no) Fremgangsmaate for behandling av voerter.
ES530508A0 (es) Un metodo de preparar 2'-desoxioxanosina
FR2540116B1 (fr) Nouvel antibiotique et antitumoral, la luzopeptine e2, son procede de preparation, et les compositions pharmaceutiques utilisant cet antibiotique
DE3576498D1 (de) 2-sulfamoyl-1h-indole-derivate zur behandlung von hohem intraocularem druck.
ATE18056T1 (de) 14-amino-steroidderivate, verfahren zu ihrer herstellung und ihre therapeutische anwendung.
ATE33828T1 (de) Verfahren zur herstellung von 1-hydroxylierten vitamin d derivaten.
ATE22446T1 (de) Derivate von 2-beta-d-ribofuranosylselenazol-4carboxamid und methode zu ihrer herstellung.
ES530518A0 (es) Aparato de dilucion, especialmente para la fabricacion de medicamentos homeopaticos.
ATE25842T1 (de) Verfahren zur herstellung von verbindungen der vitamin k-reihe und von ubichinonen, sowie neue zwischenprodukte.
FI880080A0 (fi) Foerfarande foer framstaellning av 1,2,3,4-tetrahydro-5h-(1)bensopyrano-(3,4-c)pyridin-5-on.
BR8001166A (pt) Processo para o tratamento de produtos agricolas

Legal Events

Date Code Title Description
PBP Patent lapsed